Problem

Healthcare is often episodic and fragmented: traditional primary-care visits are short, office-hours constrained, and may miss patterns across a patient’s conditions, labs, medications, and wearable data. That creates continuity and access problems while leaving patients to pay per-visit costs or substantially more for concierge care. Clara positions its $25–$150 monthly membership against traditional PCP copays of $150 or more per visit and concierge offerings that may charge $2,000 or more to enroll.

The killer use case is proactive, continuous primary care for someone who wants an always-available health layer rather than starting from scratch at every appointment. Clara is designed to read a patient’s complete history, identify trends and risks, and help manage refills, lab orders, prevention, and longevity in context.

Product / Service

Clara is an AI-first, direct-to-consumer primary-care practice. It securely pulls medical histories from more than 150,000 hospitals, labs, and pharmacies, reads the information whenever a patient interacts with it, and drafts prescription refills, lab orders, and care plans. A licensed clinician in the patient’s state reviews and signs off on every clinical decision; Clara says it is available as a primary-care provider or alongside an existing PCP and is licensed in all 50 states.

The service is sold through cash-pay memberships: Basic costs $25 per month for unlimited AI chats, records synchronization, and physician-reviewed prescription and lab orders; Standard costs $50 and adds wearables, video visits, and biomarker testing; Concierge costs $150 and adds a broader set of tests and panels. The plans are HSA/FSA eligible, while prescriptions and some ad-hoc lab work may be covered separately by insurance. The benefit is round-the-clock, context-rich access at a lower recurring price than many concierge or episodic-care alternatives, with clinician oversight rather than an unreviewed chatbot.

Market

Clara competes in AI-first primary care and longevity medicine, overlapping with virtual primary-care providers, concierge medicine, traditional PCPs, and consumer health-AI products. K Health is an adjacent AI-powered primary-care competitor, while Claude and ChatGPT represent the generic-AI alternatives Clara explicitly distinguishes itself from. Clara’s differentiation is the combination of longitudinal medical-record access, the ability to initiate care workflows such as prescriptions and lab orders, state-licensed clinicians, and physician review of clinical decisions.

The company launched in May 2026 and is listed by Y Combinator as an active Spring 2026 company founded in 2025, with a team of nine. It has raised a $12 million pre-seed round led by Y Combinator and A.Capital, with additional venture and angel participation, and was built by the team behind Circle Medical, which previously exceeded $100 million in annual revenue. No public patient-count, revenue, or utilization figures are disclosed in the available sources, so Clara’s demonstrated traction is currently its launch, funding, licensing, and experienced team rather than proven commercial scale.